{
    "2019-06-07": [
        [
            {
                "time": "2018-06-04",
                "original_text": "Hereâ€™s What Hedge Funds Think About Eli Lilly and Company (LLY)",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Eli Lilly",
                        "LLY"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache",
                "features": {
                    "keywords": [
                        "ASCO",
                        "FDA",
                        "LLY",
                        "Emgality",
                        "Cluster Headache"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}